TP53 and hepatocellular carcinoma: To verify that ZNF498 exerts effects on HCC in a p53-dependent manner in clinical samples, we collected TP53 mutational information from the TCGA HCC cohort and found that the correlation between ZNF498 expression and patient outcome was significant only in those with wild-type TP53 (Fig. 6I and J).